GPX4 and neoplasm: Recently, several compounds including ML162 [45], RSL3 [46], and DPI [47] were reported to inhibit GPX4 and GSH activity, and promotes MDA activity thereby inducing ROS-mediated ferroptosis induction in tumor cells.